Last reviewed · How we verify
Eldisine (VINDESINE)
Eldisine (generic name: VINDESINE) is a vindesine drug. It is currently FDA-approved for Acute lymphoid leukemia, Chronic myeloid leukemia, Malignant melanoma.
Eldisine is a small molecule used in cancer treatment. It has been studied in combination with Rituximab, Mitoxantrone hydrochloride liposome, and Cyclophosphamide for the treatment of various conditions, including Diffuse Large B-cell Lymphoma, Leukemia, Neuroblastoma, and Adult T-cell Leukemia/Lymphoma.
At a glance
| Generic name | VINDESINE |
|---|---|
| Drug class | vindesine |
| Target | Cytochrome P450 3A4 |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
- Acute lymphoid leukemia
- Chronic myeloid leukemia
- Malignant melanoma
- Malignant tumor of lung
Common side effects
Key clinical trials
- Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy (PHASE2)
- Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) (PHASE3)
- LBL-2016 for Children or Adolescents in China (PHASE3)
- Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment (PHASE3)
- Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients (PHASE2)
- Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL (PHASE2,PHASE3)
- High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (PHASE3)
- FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Eldisine CI brief — competitive landscape report
- Eldisine updates RSS · CI watch RSS
Frequently asked questions about Eldisine
What is Eldisine?
What is Eldisine used for?
What is the generic name of Eldisine?
What drug class is Eldisine in?
What development phase is Eldisine in?
What does Eldisine target?
Related
- Drug class: All vindesine drugs
- Target: All drugs targeting Cytochrome P450 3A4
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Acute lymphoid leukemia
- Indication: Drugs for Chronic myeloid leukemia
- Indication: Drugs for Malignant melanoma
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing